News & Trends - Pharmaceuticals
Lifecycle approach: Main themes from HTAi and relevance for Australia’s HTA reforms
Pharma News: Calls for a lifecycle approach to determine the value of medicines, medical devices and other health services have grown over recent years in response to the challenges of innovative and novel technologies, disconnected and disparate stakeholders and data requirements, public expectations and achieving patient-centric health systems.
Ann Single, steering committee member at Patient Voice Initiative (PVI) and co-chair of the international scientific program committee at the recent HTAi (Health Technology Assessment International) conference, joined Health Industry Hub to reflect on the main themes from the meeting that have the most relevance and significance for Australia’s HTA reforms.
Medical
NSW Health to settle ‘largest’ class action
A class action alleging NSW Health underpaid clinicians has settled after the department agreed to a payout of nearly a […]
MoreNews & Trends - Pharmaceuticals
Lilly’s first-in-class therapy PBS listed for early breast cancer after 15-year gap
Pharma News: Australians diagnosed with early-stage breast cancer, particularly those at high risk of recurrence, will gain access to the […]
MoreNews & Trends - Pharmaceuticals
AstraZeneza secures four PBAC nods in oncology, diabetes, kidney and rare diseases
Pharma News: AstraZeneca has scored four positive Pharmaceutical Benefits Advisory Committee (PBAC) recommendations following the March meeting. These recommendations, spanning […]
MoreNews & Trends - Pharmaceuticals
PBAC recommendation to reshape prescribing in heart failure
Pharma News: Aligned with the government’s Scope of Practice Review, the Pharmaceutical Benefits Advisory Committee (PBAC) has made a practice-changing […]
More